今海医疗科技的创新不仅限于硬件设备，还积极推进了“荧光+人工智能(AI)”技术的研发。其首创的AI超高清内窥镜系统也已于2023年4月11日在第89届中国国际医疗器械博览会(CMEF)上首次亮相，展示了今海医疗在AI领域的潜力与前沿探索。Shanghai's China Healthcare Technology (02225) has made it to the 2024 Qipu Award Seed List.
According to the Securities Times app, on Tuesday, the highly anticipated China Health Industry "Qipu Award" announced the shortlist for the "Seed List" for the year 2024. Shanghai's China Healthcare Technology Co., Ltd. (02225) successfully made it through the initial review stage with its 4K naked-eye 3D fluorescent intelligent navigation endoscope system. As an innovative force in the medical and health industry, China Healthcare Technology emerged in the fierce competition, showcasing its outstanding technological strength and industry prospects.
In recent years, China Healthcare Technology has achieved many important breakthroughs in endoscopic technology research and development, covering a series of products from the 4K ultra-high-definition endoscope system to 3D and naked-eye 3D image processing systems, and then to the 4K fluorescent and future multi-spectral ultra-high-definition endoscope systems. Particularly noteworthy is the company's latest launch of the Endo Next series true 4K 3D 4MOS ultra-high-definition fluorescent endoscope system, which was successfully launched in July 2023. This endoscope system combines the "4K+3D+fluorescence" three-in-one technology, providing a more precise solution for the field of minimally invasive surgery.
China Healthcare Technology's innovation is not limited to hardware equipment, but it is also actively promoting the research and development of "fluorescence + artificial intelligence (AI)" technology. Its pioneering AI ultra-high-definition endoscope system was first unveiled at the 89th China International Medical Equipment Fair (CMEF) on April 11, 2023, showcasing China Healthcare Technology's potential and frontier exploration in the AI field.
As an innovative event that is highly sought after in the Chinese health industry, the Qipu Award, with its rigorous review standards and highly recognized status, is hailed as the "Oscar" of the medical and health industry. The establishment of the Qipu Seed List is focused on early-stage projects that have yet to be commercialized, aiming to realize the value of innovative health industry projects by connecting industry, investment, academic, and government resources.
